Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer-Reference-Cited by-同舟云学术

Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

Published:2017-11 Issue: Volume:86 Page:385-393
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Park Yeon Hee,Im Seock-Ah,Kim Sung-Bae,Sohn Joo Hyuk,Lee Keun Seok,Chae Yee Soo,Lee Ki Hyeong,Kim Jee Hyun,Im Young-Hyuck,Kim Ji-Yeon,Kim Tae-Yong,Lee Kyung-Hun,Ahn Jin-Hee,Kim Gun Min,Park In Hae,Lee Soo Jung,Han Hye Sook,Kim Se Hyun,Jung Kyung Hae

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014;Jung;Cancer Res Treat,2017

3. Treatment of metastatic breast cancer in a real-world scenario: is progression-free survival with first line predictive of benefit from second and later lines?;Bonotto;Oncologist,2015

4. Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389;Kuznetsov;Cancer Res,2004

5. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability;Smith;Biochemistry,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Efficacy, Safety and Predictive Indicators of Eribulin Plus Anti-Angiogenic Medicine for Metastatic Breast Cancer;Journal of the College of Physicians and Surgeons Pakistan;2024-06-01

2. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study;Frontiers in Cell and Developmental Biology;2024-02-22

3. Analysis of the metastatic mechanism and progress in the treatment of breast cancer liver metastasis: a narrative review;Translational Cancer Research;2023-06

4. Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms;Cell Death Discovery;2023-05-13

5. Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas;International Journal of Molecular Sciences;2022-12-30